CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale 10b5-1 | −1,327 | $35.69 | $47K | 7,717 |
| 2025-02-19 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +12,287 | 12,287 | ||
| 2025-02-19 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Grant or award · Restricted Stock Unit Award 10b5-1 | +11,965 | 11,965 | ||
| 2025-02-19 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,417 | 50,417 | ||
| 2025-02-19 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Restricted Stock Unit Award | +24,182 | 24,182 | ||
| 2025-02-19 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Employee Stock Option (Right to Buy) | +63,991 | 63,991 | ||
| 2025-02-19 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +30,692 | 30,692 | ||
| 2025-02-19 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +77,565 | 77,565 | ||
| 2025-02-19 | Jackson Blair Curtis EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit Award | +37,203 | 37,203 | ||
| 2025-02-19 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +63,991 | 63,991 | ||
| 2025-02-19 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Restricted Stock Unit Award | +30,692 | 30,692 | ||
| 2025-02-19 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +293,921 | 293,921 | ||
| 2025-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise 10b5-1 | +2,033 | 9,750 | ||
| 2025-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes 10b5-1 | −706 | $35.90 | $25K | 9,044 |
| 2025-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award 10b5-1 | −2,033 | 2,034 | ||
| 2025-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,354 | 84,223 | ||
| 2025-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,869 | $35.90 | $67K | 82,354 |
| 2025-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,354 | 6,355 | ||
| 2025-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +6,354 | 194,853 | ||
| 2025-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,822 | $35.90 | $101K | 192,031 |
Page 17 of 41 · 804 trades